[Markers of hepatitis virus].
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the major viruses known to cause viral hepatitis. Serological markers are commonly used as diagnostic and/or prognostic indicators of acute or chronic HBV or HCV infection. The ability to detect HBV DNA in serum has been reported to have prognostic value for the outcome of chronic HBV infection. A rapid and sustained drop in HBV DNA or HCV RNA levels in patients under therapy has been shown to be a predictive factor for a favourable treatment outcome. Various techniques for detecting HBV DNA or HCV RNA have already been described; however, there are various problems with the sensitivity or detection range of those methods. New virus measuring methods have recently been reported and used. The Cobas Taq Man HCV Test is a new method to detect HBV DNA and HCV RNA with higher sensitivity and a broader range of quantitation than conventional methods. Some reports have shown that these methods improve therapy monitoring and the management of HBV or HCV infection. Moreover, hepatitis E virus (HEV) infection has been reported in Japan. The clinical features and viral markers of HEV have also been described.
Suzuki
Fumitaka
F
Department of Hepatology, Toranomon Hospital, Tokyo 105-8470, Japan. fumitakas@toranomon.gr.jp
D015415:Biomarkers / Q000097:blood; D004279:DNA, Viral / Q000097:blood*; D016174:Hepacivirus / Q000235:genetics*; D006509:Hepatitis B / Q000175:diagnosis*; D006515:Hepatitis B virus / Q000235:genetics*; D006526:Hepatitis C / Q000175:diagnosis*; D016751:Hepatitis E / Q000175:diagnosis; D016752:Hepatitis E virus / Q000235:genetics; D006801:Humans; D021141:Nucleic Acid Amplification Techniques / Q000379:methods*; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood*; D012680:Sensitivity and Specificity
D015415:Biomarkers; D004279:DNA, Viral; D012367:RNA, Viral